A new biomarker can better predict meningioma response to radiation
This new biomarker offers insights into how meningioma patients with different gene expression patterns respond differently to treatments
Read More
meningioma
Molecular profiling of meningioma can lead to improved prognosis and therapy
The researchers hope that a molecular classification of meningioma will replace the traditional histopathological classification in the near future.
Read More
Molecular profiling of meningioma hints at tumor behavior
Meningiomas, the most common primary brain tumors, are typically benign. One-fifth of them, however, recur despite complete surgical removal. Reliably predicting whether a patient’s tumor
Read More